- Home
- EVAX vs CCTG Comparison
EVAX vs CCTG Comparison
Compare EVAX & CCTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- CCTG
- Stock Information
- Founded
- EVAX 2008
- CCTG 1993
- Country
- EVAX Denmark
- CCTG Hong Kong
- Employees
- EVAX N/A
- CCTG N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- CCTG
- Sector
- EVAX Health Care
- CCTG
- Exchange
- EVAX Nasdaq
- CCTG Nasdaq
- Market Cap
- EVAX 16.3M
- CCTG 14.9M
- IPO Year
- EVAX 2021
- CCTG 2024
- Fundamental
- Price
- EVAX $1.64
- CCTG $1.24
- Analyst Decision
- EVAX Strong Buy
- CCTG
- Analyst Count
- EVAX 2
- CCTG 0
- Target Price
- EVAX $10.00
- CCTG N/A
- AVG Volume (30 Days)
- EVAX 64.1K
- CCTG 13.3K
- Earning Date
- EVAX 05-27-2025
- CCTG 12-27-2024
- Dividend Yield
- EVAX N/A
- CCTG N/A
- EPS Growth
- EVAX N/A
- CCTG N/A
- EPS
- EVAX N/A
- CCTG N/A
- Revenue
- EVAX $3,344,000.00
- CCTG $16,463,490.00
- Revenue This Year
- EVAX $102.45
- CCTG N/A
- Revenue Next Year
- EVAX $100.30
- CCTG N/A
- P/E Ratio
- EVAX N/A
- CCTG N/A
- Revenue Growth
- EVAX 4480.82
- CCTG 3.27
- 52 Week Low
- EVAX $1.20
- CCTG $1.16
- 52 Week High
- EVAX $20.81
- CCTG $3.17
- Technical
- Relative Strength Index (RSI)
- EVAX 55.67
- CCTG 41.06
- Support Level
- EVAX $1.42
- CCTG $1.16
- Resistance Level
- EVAX $1.62
- CCTG $1.28
- Average True Range (ATR)
- EVAX 0.11
- CCTG 0.07
- MACD
- EVAX 0.03
- CCTG 0.00
- Stochastic Oscillator
- EVAX 62.86
- CCTG 44.00
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About CCTG CCSC Technology International Holdings Limited
CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.